T. Rowe Price Associates’s Amrize Ltd AMRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Buy
212,258
+20,000
+10% +$1.15M ﹤0.01% 1175
2025
Q4
$10.4M Buy
192,258
+3,500
+2% +$179K ﹤0.01% 1225
2025
Q3
$9.16M Buy
+188,758
New +$9.63M ﹤0.01% 1247

Other funds holding AMRZ

T. Rowe Price Associates's AMRZ Position: Q1 2026 in Review

T. Rowe Price Associates increased its Amrize Ltd (AMRZ) stake by 10% in Q1 2026, buying an estimated $1.15M and bringing the position to 212,258 shares worth $11.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1175.

T. Rowe Price Associates first reported a position in AMRZ in Q3 2025 and has held it in 3 quarters since. 447 funds tracked by Wall St. Rank hold AMRZ as of Q1 2026.

  • T. Rowe Price Associates held 212,258 shares of Amrize Ltd worth $11.9M as of Q1 2026.
  • T. Rowe Price Associates bought 20,000 Amrize Ltd shares in Q1 2026, an estimated $1.15M.
  • Amrize Ltd made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1175 holding.
  • T. Rowe Price Associates first reported a position in Amrize Ltd in Q3 2025 and has held it in 3 quarters since.
  • 447 funds tracked by Wall St. Rank held Amrize Ltd as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.